Showing results (131-140 of 202) with videos related to

Sort By:
Pageof 21
AIDS and Behavior|July 31, 2024
Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP TrialStanley E Cooper, Shuaiqi Zhang, Daniel Haines, et al.
AIDS (London, England)|October 23, 2003
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudineRoy M Gulick, Anne Meibohm, Diane Havlir, et al.
The Journal of Infectious Diseases|July 23, 2002
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850)Arlene S Pereira, Laura M Smeaton, John G Gerber, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonistsTimothy J Henrich, Nicolas R P Lewine, Sun-Hee Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211Timothy J Wilkin, Zhaohui Su, Daniel R Kuritzkes, et al.
Topics in Antiviral Medicine|February 17, 2017
A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and CareConstance A Benson, Judith S Currier, Carlos Del Rio, et al.
HIV Clinical Trials|January 25, 2008
Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patientsRobert L Murphy, Barbara A da Silva, Charles B Hicks, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 2, 2010
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participantsBenjamin J Grady, Eric S Torstenson, Paul J McLaren, et al.
The Journal of Infectious Diseases|March 16, 2007
Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166sDaniel R Kuritzkes, Heather J Ribaudo, Kathleen E Squires, et al.
Open Forum Infectious Diseases|March 4, 2015
Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group StudyTimothy J Henrich, Paul J McLaren, Suhas S P Rao, et al.
Pageof 21